Pharmacotherapeutic potential of ginger and its compounds in age-related neurological disorders

Pharmacol Ther. 2018 Feb;182:56-69. doi: 10.1016/j.pharmthera.2017.08.010. Epub 2017 Aug 24.


Age-related neurological disorders (ANDs), including neurodegenerative diseases, are multifactorial disorders with a risk that increases with aging. ANDs are generally characterized by common neuropathological conditions of the central nervous system, such as oxidative stress, neuroinflammation, and protein misfolding. Recently, efforts have been made to overcome ANDs because of the increase in age-dependent prevalence. Ginger, the rhizome of Zingiber officinale Roscoe, is a popular food spice and has a long history of use in traditional medicine for treating various disease symptoms. The structure-activity relationships of ginger phytochemicals show that ginger can be used to treat ANDs by targeting different ligand sites. This review shows that ginger and its constituents, such as 6-gingerol, 6-shogaol, 6-paradol, zingerone, and dehydrozingerone, are effective for ameliorating the neurological symptoms and pathological conditions of ANDs through by modulating cell death or cell survival signaling molecules. From this review, we conclude that the active ingredients in ginger have therapeutic potential in ANDs.

Keywords: 6-gingerol; 6-shogaol; Age-related neurological disorders; Ginger; Zingerone.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Age Factors
  • Animals
  • Ginger*
  • Humans
  • Nervous System Diseases / drug therapy*
  • Phytochemicals / therapeutic use*
  • Plant Extracts / therapeutic use*
  • Signal Transduction / drug effects*


  • Phytochemicals
  • Plant Extracts